Clinical Trial Update: Fexofenadine Versus Gabapentin for Uremic Pruritus in Patients on Regular Hemodialysis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing fexofenadine to gabapentin for uremic pruritus in patients on regular hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease-associated Pruritus
• End-stage Renal Disease
• Uremic Pruritus

Drugs mentioned

• Fexofenadine (fexofenadine)
• Gabapentin (Gabapentin)

Snippet

Sponsor: Tanta University | Conditions: Uremic Pruritus, Chronic Kidney Disease-associated Pruritus | Phase 4 | Status: COMPLETED